Focal Healthcare (OBIO Pre-CAAP 2015) announced it has received both FDA 510(k) clearance and Health Canada approval for its Fusion Bx™ 2.0 prostate biopsy solution, which is now available for sale in the United States and Canada. 

Winterlight’s cognitive assessment detected significant improvement for treatment relative to placebo in Cortexyme's Phase 1B trial for Alzheimer’s disease using COR388; a bacterial protease inhibitor.

Researchers are invited to apply for funding through AGE-WELL’s Core Research Program 2020 to 2025, and if renewed, AGE-WELL will provide over $16 million for projects.

Intellijoint was the recipient of the inaugural Waterloo MedTech Start-Up to Scale-Up Award of Excellence at the 3rd Annual Waterloo MedTech Conference.

Think Research has successfully completed its planned capital raise of over $25 million to further their ability to enhance their product line, advance machine learning capabilities and continue expanding into new markets.

KA Imaging was featured in Vanguard Magazine as a 2018 Technology Showcase participant for this year's Best Defence Conference.

BrainFX won the iGan Pitch-to-Heal Competition, which secured them a $500,000 investment as part of a larger $1 Million co-investment round.

Braze Mobility was awarded AGE-WELL's newly launched Emerging Entrepreneur Award, a salary award for those seeking to turn their innovation into a viable business through a start-up company. 

Conavi Medical announced that Japan Lifeline, their exclusive distributor, has submitted an application for the regulatory approval of the NovaSight Hybrid intravascular imaging system in Japan.

Starting in March 2019, Carleton Physics Prof. Manuella Vincter will be the Deputy Spokeperson of the ATLAS project, the largest particle detector ever built and one of four major experiments at the Large Hadron Collider particle accelerator.

Connection Silicon Valley, which helps Canadian startups connect with the Silicon Valley ecosystem, has announced that applications are now open for the Canadian Women’s Network Fall Cohort.

The Centre for Commercializing Regenerative Medicine (CCRM) and the University Health Network (UHN) have opened a new Centre for Cell and Vector Production which will produce clinical-grade cells and viral vectors for Phase 1 and 2 clinical trials. 

iBionics received a $5,000 grant from the Women Founders Fund, which aims to alleviate some of the financial barriers women in the STEM industry face when starting and accessing opportunities for business and professional growth.

Flosonics was named a finalist for 2018 Ontario Centres of Excellence Martin Walmsley Award for Entrepreneurship, which carried a prize of $25,000.

RetiSpec will collaborate with the University of Minnesota to commercialize their technology for early detection of Alzheimer’s disease.

TR Talks is hosted by the University of Toronto's Translational Research Program (TRP) and is intended to provoke discussion and community building. The next talk will be October 30th on the topic of "Pathways to Market: Post clinical trials." 

The Consulate General of Canada in Chicago, in partnership with the Chicago Innovation Mentors (CIM), is offering the opportunity to participate in a comprehensive mentoring program to five Canadian life science and healthcare start-ups.

Through the partnership, Stryker's will offer Synaptive’s BrightMatter™ Plan software, which automatically generates high-fidelity, dynamic, whole-brain tractography. 

ManagingLife's CEO Tahir Janmohamed discussed recent partnerships and plans for the future in an article titled, "Biomedical Zone gives startups place to validate in clinical settings."